UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
The New England journal of medicine, ISSN 0028-4793, 07/2017, Volume 377, Issue 4, pp. 338 - 351
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Prednisolone - adverse effects | Steroid 17-alpha-Hydroxylase - antagonists & inhibitors | Prostatic Neoplasms - radiotherapy | Prednisolone - administration & dosage | Prostatic Neoplasms - surgery | Humans | Middle Aged | Abiraterone Acetate - adverse effects | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Neoplasm Recurrence, Local - drug therapy | Male | Prostate-Specific Antigen - blood | Prostatic Neoplasms - mortality | Abiraterone Acetate - administration & dosage | Neoplasm Metastasis - drug therapy | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Survival Analysis | Aged, 80 and over | Adult | Aged | Androgen Antagonists - administration & dosage | Androgen Antagonists - adverse effects | Prostatic Neoplasms - drug therapy | Androgen suppression therapy | Usage | Care and treatment | Prostate cancer | Prednisolone | Medical research | Prostate-specific antigen | Clinical trials | Endocrine therapy | Oncology | Metastasis | Radiation therapy | Cancer therapies | Metastases | Mens health | Androgens | Medical prognosis | Death | Prostate | Index Medicus | Abridged Index Medicus
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2015, Volume 387, Issue 10024, pp. 1163 - 1177
Internal Medicine | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Imidazoles - administration & dosage | Male | Antineoplastic Agents, Hormonal - adverse effects | Neoplasm Metastasis | Aged, 80 and over | Adult | Diphosphonates - adverse effects | Prostatic Neoplasms - drug therapy | Taxoids - adverse effects | Drug Administration Schedule | Antineoplastic Agents, Hormonal - administration & dosage | Imidazoles - adverse effects | Docetaxel | Kaplan-Meier Estimate | Treatment Outcome | Diphosphonates - administration & dosage | Zoledronic Acid | Disease Progression | Taxoids - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Aged | Androgen Antagonists - administration & dosage | Androgen Antagonists - adverse effects | Survival analysis | Medical prognosis | Clinical trials | Hormone replacement therapy | Metastasis | Prostate cancer | Cancer therapies | Index Medicus | Abridged Index Medicus
Journal Article
European journal of cancer (1990), ISSN 0959-8049, 10/2017, Volume 84, pp. 88 - 101
Systematic review | Androgen deprivation therapy | Abiraterone | Prostate cancer | Metastases | Meta-analysis | Life Sciences & Biomedicine | Oncology | Science & Technology | Neoplasms, Hormone-Dependent - mortality | Age Factors | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Antineoplastic Agents, Hormonal - adverse effects | Neoplasm Grading | Time Factors | Antineoplastic Agents, Hormonal - therapeutic use | Prednisolone - therapeutic use | Odds Ratio | Prostatic Neoplasms - drug therapy | Prostatic Neoplasms - pathology | Androstenes - adverse effects | Risk Factors | Androstenes - therapeutic use | Treatment Outcome | Clinical Trials as Topic | Lymphatic Metastasis | Chi-Square Distribution | Prostatic Neoplasms - mortality | Disease-Free Survival | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Neoplasms, Hormone-Dependent - pathology | Androgen Antagonists - therapeutic use | Aged | Neoplasms, Hormone-Dependent - drug therapy | Androgen Antagonists - adverse effects | Prednisone - therapeutic use | Metastasis | Hormones | Analysis | Therapy | Deprivation | Toxicity | Endocrine therapy | Clinical trials | Prednisone | Survival | Subgroups | Confidence intervals | Reduction | Randomization | Men | Acetic acid | Heart diseases | Prostate | Endocrinology | Prednisolone | Cancer | Acute toxicity | Index Medicus
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 02/2014, Volume 63, Issue 7, pp. 636 - 646
meta-analysis | cardiovascular disease | prognostic factor | pulse wave velocity | Cardiac & Cardiovascular Systems | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Cardiology. Vascular system | Heart | Biological and medical sciences | Medical sciences | Predictive Value of Tests | Cardiovascular Diseases - physiopathology | Prospective Studies | Humans | Cardiovascular Diseases - epidemiology | Observational Studies as Topic | Pulse Wave Analysis - methods | Aorta - physiology | Cardiovascular Diseases - diagnosis | Sex | Cardiovascular disease | Systematic review | Subgroups | Risk factors | Confidence intervals | Ethics | Population | Aorta | Heart diseases | Age | Hypertension | Stroke | Mortality | Diabetes mellitus | Health risks | Risk analysis | Estimates | Velocity | Reclassification | Coronary artery disease | Meta-analysis | Studies | Statistical models | Predictions | Models | Diabetes | Wave velocity | Cardiovascular diseases | Health risk assessment | Risk management | Index Medicus | Abridged Index Medicus
Journal Article
Clinical trials (London, England), ISSN 1740-7745, 10/2017, Volume 14, Issue 5, pp. 451 - 461
randomised trials | basket | multi-stage | umbrella | platform | Multi-arm | Life Sciences & Biomedicine | Medicine, Research & Experimental | Science & Technology | Research & Experimental Medicine | Clinical Trials, Phase III as Topic | Humans | London | Clinical Protocols - standards | Male | Treatment Outcome | Outcome Assessment, Health Care | Research Design | Patient Selection | Randomized Controlled Trials as Topic | Clinical trials | Medical research | Design improvements | Index Medicus
Journal Article
European urology, ISSN 0302-2838, 2014, Volume 67, Issue 6, pp. 1028 - 1038
Urology | Control arm cohort | Hormone-naïve | Time to progression | Metastatic | Prospective data | Prostate cancer | Survival | Natural history | Prognostic factors | Life Sciences & Biomedicine | Urology & Nephrology | Science & Technology | Prognosis | Age Factors | Follow-Up Studies | Humans | Middle Aged | Male | Prostatic Neoplasms - diagnosis | Taxoids - therapeutic use | Neoplasm Grading | Aged, 80 and over | Adult | Physical Fitness | Prostatic Neoplasms - drug therapy | Prostatic Neoplasms - pathology | Neoplasm Metastasis - therapy | Risk Factors | Docetaxel | Kaplan-Meier Estimate | Proportional Hazards Models | Treatment Outcome | Early Detection of Cancer - mortality | Prostate-Specific Antigen - blood | Prostatic Neoplasms - mortality | Disease-Free Survival | Neoplasm Metastasis - pathology | Neoplasm Metastasis - diagnosis | Androgen Antagonists - therapeutic use | Aged | Cohort Studies | Metastasis | Index Medicus
Journal Article
BMC public health, ISSN 1471-2458, 2013, Volume 13, Issue 1, pp. 604 - 604
Screening | Self-esteem | Negative emotions | Adolescents | Self-harm | Life Sciences & Biomedicine | Public, Environmental & Occupational Health | Science & Technology | Predictive Value of Tests | Prospective Studies | Humans | England | Male | Psychometrics | Adolescent Health Services | Self-Injurious Behavior - diagnosis | Affect | Self Concept | Adolescent | Female | Surveys and Questionnaires | Adolescent Behavior | Child | Cohort Studies | High schools | Self-destructive behavior | Depression, Mental | Child psychopathology | Studies | Medical research | Teenagers | Self esteem | Self destructive behavior | Suicides & suicide attempts | Index Medicus
Journal Article
JAMA neurology, ISSN 2168-6149, 03/2014, Volume 75, Issue 1, pp. 543 - 552
Clinical Neurology | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Ubiquinone - administration & dosage | Prospective Studies | Double-Blind Method | Antioxidants - metabolism | Humans | Middle Aged | Ubiquinone - analogs & derivatives | Male | Treatment Outcome | Parkinson Disease - drug therapy | Dose-Response Relationship, Drug | Ubiquinone - blood | Parkinson Disease - enzymology | Antioxidants - administration & dosage | Parkinson Disease - diagnosis | Female | Aged | Early Diagnosis | Index Medicus | Abridged Index Medicus
Journal Article